Filing Details

Accession Number:
0001104659-22-042917
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-04-05 19:41:45
Reporting Period:
2022-04-01
Accepted Time:
2022-04-05 19:41:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1609550 Inspire Medical Systems Inc. INSP Surgical & Medical Instruments & Apparatus (3841) 261377674
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1737133 Richard Buchholz C/O Inspire Medical Systems, Inc.
5500 Wayzata Blvd., Suite 1600
Golden Valley MN 55416
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-02-17 250 $0.00 62,426 No 5 G Direct
Common Stock Acquisiton 2022-02-17 125 $0.00 1,125 No 5 G Indirect By Daughter
Common Stock Acquisiton 2022-02-17 125 $0.00 1,125 No 5 G Indirect By Son
Common Stock Disposition 2022-02-18 250 $0.00 62,176 No 5 G Direct
Common Stock Acquisiton 2022-02-18 125 $0.00 1,125 No 5 G Indirect By Son
Common Stock Acquisiton 2022-02-18 125 $0.00 1,125 No 5 G Indirect By Son
Common Stock Disposition 2022-04-01 5,500 $259.46 56,676 No 4 S Direct
Common Stock Disposition 2022-04-01 5,362 $258.50 51,314 No 4 S Direct
Common Stock Disposition 2022-04-01 4,037 $257.90 47,277 No 4 S Direct
Common Stock Disposition 2022-04-01 101 $255.99 47,176 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 5 G Indirect By Daughter
No 5 G Indirect By Son
No 5 G Direct
No 5 G Indirect By Son
No 5 G Indirect By Son
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Includes 52 shares acquired under the Inspire Medical Systems, Inc. (the "Company") 2018 Employee Stock Purchase Plan on December 31, 2021.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.10 to $259.675. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.04 to $259.01. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.04 to $258.03. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.